Profile picture for user vlking00

Victoria L. King, PhD


Center for Clinical and Translation Science, Rm: C347, 800 Rose Street, Lexington, KY 40536-0298


  • Associate Professor

College Unit(s)

Other Affiliation(s)
  • Internal Medicine - Cardiology
  • Nutritional Sciences Graduate Faculty

Biography and Education


University of Kentucky, Lexington, KY




University of Kentucky, Lexington, KY



Pharmaceutical Sciences

University of Kentucky, Lexington, Kentucky



Cardiovascular Medicine

Selected Publications

1.King VL, Szilvassy SJ, Daugherty A. Interleukin 4 deficiency decreases atherosclerotic lesion formation in a site specific manner in female LDL receptor / mice. Arterioscler Thromb Vasc Biol. 2002; Mar 1;22(3):456 61. 2. King VL, Trivedi D, Gitlin J.R., Loftin CD. Selective cyclooxygenase-2 inhibition with celecoxib decreases angiotensin II-induced abdominal aortic aneurysm formation in mice. Arterioscler Thromb Vasc Biol 2006 May;26(5):1137-43. 3. King VL, Cassis LA, Daugherty A. Interleukin-4 does not influence development of hypercholesterolemia or angiotensin II-induced atherosclerotic lesions. Am. J. Pathol. 2007 171: 2040-2047. 4. Arsenescu V, Arsenescu RI, King VL, Swanson H, Cassis LA. Polychlorinated Biphenyl 77 Induces Adipocyte Differentiation and Proinflammatory Adipokines and Promotes Obesity and Atherosclerosis. Environ Health Perspect 2008; 116(6); 761-768. 5. Wilson P, Thompson JC, Webb NR, King VL, Tannock LR. Serum Amyloid A, but not C-Reactive Protein Stimulates Vascular Proteoglycan Synthesis in a Pro-Atherogenic Manner. Am. J. Pathol. 2008; 173(6): 1902-1910.

Research Gate Pubmed Publications